Survey on the Place of Community Pharmacists in the Detection of Cannabis Use: a Student's Point of View (CANNACY)
July 5, 2017 updated by: University Hospital, Clermont-Ferrand
The objective of this survey will be to evaluate the perception by the students (except for medical students, pharmacies) of community pharmacists concerning the management of cannabis consumption.
We want to see if the student population perceives the pharmacist as the public health actor of choice, and if they would more easily turn to him or to another health professional (doctor, nurse) in case they need.
Discussing possible problematic consumption or for a simple search for information.
It will be assessed whether the pharmacist seems to be a good candidate and an element of choice when young adults want to take an intelligence approach to cannabis consumption.
Study Overview
Detailed Description
This observational and transversal study will be conducted as a survey using the REDCap software and the response to this survey will be done online, in real time, with an automatic, secure and centralized data collection (CHU Clermont-Ferrand).
Students of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scholarity departments. Answer to the survey will be done online via the following link https://redcap.chu-clermontferrand.fr/surveys/?s=JMRF9FLRJP.
Study Type
Observational
Enrollment (Actual)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Auvergne
-
Clermont-Ferrand, Auvergne, France, 63003
- CHU Clermont-Ferrand
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The young and student populations are particularly affected by the use of addictive substances, including alcohol, tobacco and cannabis.
Students of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scolarity departments.
Answer to the survey will be done online.
Description
Inclusion Criteria:
- Student following a university path in the Auvergne Rhone Alpes region
Exclusion Criteria:
- Medical student
- Pharmacy student
- age < 18-year
- Other than student
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Students
Students of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scholarity departments.
Answer to the survey will be done online.
|
This observational and transversal study will be conducted as a survey using the REDCap software and the response to this survey will be done online, in real time, with an automatic, secure and centralized data collection (CHU Clermont-Ferrand).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Role of health professionals in the prevention of cannabis addiction
Time Frame: at day 1
|
Students' perceptions (visual analogic scale) of the role of three types of health professionals (community pharmacists, general practitioners and academic health services) in the prevention of cannabis addiction
|
at day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Role of health professionals for the therapeutic management of cannabis addiction
Time Frame: at day 1
|
Assessment of students' perceptions (visual analogic scale) of the role of three types of health professionals (community pharmacists, general practitioners and academic health services) for the therapeutic management of cannabis addiction.
|
at day 1
|
|
Cannabis consumption
Time Frame: at day 1
|
yes/no
|
at day 1
|
|
Type of cannabis used
Time Frame: at day 1
|
marijuana/haschich
|
at day 1
|
|
Frequency of cannabis use
Time Frame: at day 1
|
at day 1
|
|
|
Sought effects of cannabis use
Time Frame: at day 1
|
Recreational / Stone / Therapeutic / Other expected effect
|
at day 1
|
|
Level of knowledge on cannabis
Time Frame: at day 1
|
Yes I know the risk / No I don't know the risk
|
at day 1
|
|
Consumption of cigarettes
Time Frame: at day 1
|
yes/no
|
at day 1
|
|
Consumption of e-cigarettes
Time Frame: at day 1
|
yes/no
|
at day 1
|
|
Consumption of alcohol
Time Frame: at day 1
|
yes/no
|
at day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 5, 2017
Primary Completion (ACTUAL)
June 2, 2017
Study Completion (ACTUAL)
June 2, 2017
Study Registration Dates
First Submitted
May 11, 2017
First Submitted That Met QC Criteria
May 23, 2017
First Posted (ACTUAL)
May 25, 2017
Study Record Updates
Last Update Posted (ACTUAL)
July 7, 2017
Last Update Submitted That Met QC Criteria
July 5, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHU-333
- 2017-A00328-45 (OTHER: 2017-A00328-45)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.